Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 18-Nov-24 8:02 PM View:  | Patel Samir Rashmikant Director | Akari Therapeutics Plc (AKTX) | 14-Nov-24 | Grant | 1,404,620,032 | -- | -- | 168% 834.26M to 2.15B | |
| 04-Jun-24 4:45 PM View: | Patel Samir Rashmikant Director | Akari Therapeutics Plc (AKTX) | 31-May-24 | Grant Duplicate | 1,326,259,968 | $0.00 | $1,193,630.00 | 161% 821.22M to 2.15B | |
| 04-Jun-24 4:45 PM View: | Prudo Ray Director | Akari Therapeutics Plc (AKTX) | 31-May-24 | Grant | 1,326,259,968 | $0.00 | $1,193,630.00 | 80% 1.66B to 2.15B | |
| 03-May-24 4:46 PM View: | Dicicco Wendy F Interim CFO | Akari Therapeutics Plc (AKTX) | 01-May-24 | Grant | 158,474,000 | -- | -- | 100% 0 to 158.47M | |
| 30-Apr-24 9:45 PM View: | Jacques Rachelle Suzanne Chief Executive Officer Director | Akari Therapeutics Plc (AKTX) | 26-Apr-24 | Grant | 479,569,984 | -- | -- | 89% 538.46M to 1.02B | |
| 22-Sep-15 5:42 PM View: | Cohen Mark S Director | Akari Therapeutics Plc (AKTX) | 18-Sep-15 | Private Purchase | 1,055,600 | $0.19 | $200,036.00 | 100% 0 to 1.06M | |
| 17-Apr-14 4:17 PM View: | Sabby Management, LLC 10% Owner | Akari Therapeutics Plc (AKTX) | 15-Apr-14 | Market Purchase | 17,100 | $5.00 | $85,500.00 | 2% 760.93K to 778.03K | (96%) |
| 17-Apr-14 4:17 PM View: | Sabby Management, LLC 10% Owner | Akari Therapeutics Plc (AKTX) | 14-Apr-14 | Market Purchase | 3,000 | $5.21 | $15,630.00 | < 1% 757.93K to 760.93K | (96%) |
| 11-Apr-14 4:04 PM View: | Sabby Management, LLC 10% Owner | Akari Therapeutics Plc (AKTX) | 11-Apr-14 | Market Purchase | 100 | $5.15 | $515.00 | < 1% 757.83K to 757.93K | (96%) |
| 11-Apr-14 4:04 PM View: | Sabby Management, LLC 10% Owner | Akari Therapeutics Plc (AKTX) | 10-Apr-14 | Market Purchase | 1,400 | $5.25 | $7,350.00 | < 1% 756.43K to 757.83K | (96%) |
| 11-Apr-14 4:04 PM View: | Sabby Management, LLC 10% Owner | Akari Therapeutics Plc (AKTX) | 09-Apr-14 | Market Purchase | 1,075 | $5.51 | $5,923.25 | < 1% 755.36K to 756.43K | (96%) |
| 08-Apr-14 4:05 PM View: | Sabby Management, LLC 10% Owner | Akari Therapeutics Plc (AKTX) | 08-Apr-14 | Market Purchase | 35,500 | $5.36 | $190,280.00 | 5% 719.86K to 755.36K | (96%) |
| 08-Apr-14 4:05 PM View: | Sabby Management, LLC 10% Owner | Akari Therapeutics Plc (AKTX) | 07-Apr-14 | Market Purchase | 20,654 | $5.71 | $117,840.00 | 3% 699.2K to 719.86K | (96%) |
| 08-Apr-14 4:05 PM View: | Sabby Management, LLC 10% Owner | Akari Therapeutics Plc (AKTX) | 04-Apr-14 | Market Purchase | 12,250 | $6.07 | $74,400.00 | 2% 686.95K to 699.2K | (96%) |
| 02-Apr-14 4:04 PM View: | Sabby Management, LLC 10% Owner | Akari Therapeutics Plc (AKTX) | 02-Apr-14 | Market Purchase | 2,500 | $6.15 | $15,375.00 | < 1% 1.35M to 1.36M | (97%) |
| 02-Apr-14 4:04 PM View: | Sabby Management, LLC 10% Owner | Akari Therapeutics Plc (AKTX) | 01-Apr-14 | Market Purchase | 15,371 | $6.10 | $93,805.50 | 1% 1.34M to 1.35M | (96%) |
| 02-Apr-14 4:04 PM View: | Sabby Management, LLC 10% Owner | Akari Therapeutics Plc (AKTX) | 31-Mar-14 | Market Purchase | 7,936 | $6.35 | $50,393.60 | < 1% 1.33M to 1.34M | (97%) |
| 27-Mar-14 4:15 PM View: | Sabby Management, LLC 10% Owner | Akari Therapeutics Plc (AKTX) | 27-Mar-14 | Market Purchase | 1,700 | $6.61 | $11,237.00 | < 1% 657.04K to 658.74K | (97%) |
| 27-Mar-14 4:15 PM View: | Sabby Management, LLC 10% Owner | Akari Therapeutics Plc (AKTX) | 26-Mar-14 | Market Purchase | 14,200 | $6.66 | $94,619.00 | 2% 642.84K to 657.04K | (97%) |
| 27-Mar-14 4:15 PM View: | Sabby Management, LLC 10% Owner | Akari Therapeutics Plc (AKTX) | 25-Mar-14 | Market Purchase | 303 | $6.90 | $2,090.70 | < 1% 642.54K to 642.84K | (97%) |
| 24-Mar-14 4:04 PM View: | Sabby Management, LLC 10% Owner | Akari Therapeutics Plc (AKTX) | 24-Mar-14 | Market Purchase | 2,400 | $6.71 | $16,104.00 | < 1% 640.14K to 642.54K | (97%) |
| 24-Mar-14 4:04 PM View: | Sabby Management, LLC 10% Owner | Akari Therapeutics Plc (AKTX) | 21-Mar-14 | Market Purchase | 4,900 | $6.83 | $33,467.00 | < 1% 635.24K to 640.14K | (97%) |
| 24-Mar-14 4:04 PM View: | Sabby Management, LLC 10% Owner | Akari Therapeutics Plc (AKTX) | 20-Mar-14 | Market Purchase | 3,800 | $6.90 | $26,220.00 | < 1% 631.44K to 635.24K | (97%) |
| 02-Apr-14 4:04 PM View: | Sabby Management, LLC 10% Owner | Akari Therapeutics Plc (AKTX) | 17-Mar-14 | Market Purchase | 2,400 | $6.65 | $15,960.00 | < 1% 1.33M to 1.33M | (97%) |
